ISSN:
1573-0646
Keywords:
Acute leukemia
;
therapy
;
monoclonal antibodies
;
immunomodulation
Source:
Springer Online Journal Archives 1860-2000
Topics:
Chemistry and Pharmacology
,
Medicine
Notes:
Abstract In the last few decades, there has been a significant improvement in theprognosis of patients with acute leukemias. Still, the majority ofpatients succumb to these diseases. In recent years there has been a greatsurge in the understanding of the molecular mechanisms of disease whichhave provided us with new targets for anti-leukemia therapy. These rangefrom chemotherapeutic agents with novel mechanisms of action, such astopoisomerase I inhibitors or demethylating agents, to reversal ofdrug-resistance mechanisms, to monoclonal antibodies directed againstspecific antigens, and targeted therapy that inhibit the function ofmolecules such as tyrosine kinases or Ras. The research on many of theseagents is still in the early phases, but these new approaches offer thepromise of finding a cure for the majority of patients with leukemia inthe near future. Here we describe some of the promising approaches thatare currently being investigated in the treatment of acute leukemias.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1023/A:1006392116024
Permalink